Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery System

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1792808

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1792808

Oral Drug Delivery

PUBLISHED:
PAGES: 498 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Oral Drug Delivery Market to Reach US$180.1 Billion by 2030

The global market for Oral Drug Delivery estimated at US$125.8 Billion in the year 2024, is expected to reach US$180.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Tablets Form, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$72.6 Billion by the end of the analysis period. Growth in the Capsules Form segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$34.3 Billion While China is Forecast to Grow at 9.5% CAGR

The Oral Drug Delivery market in the U.S. is estimated at US$34.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$36.3 Billion by the year 2030 trailing a CAGR of 9.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Oral Drug Delivery Market - Key Trends & Drivers Summarized

Why Is Oral Drug Delivery the Preferred Route for Systemic Therapy?

Oral drug delivery remains the most widely used route for administering pharmaceuticals due to its convenience, non-invasiveness, and cost-effectiveness. It supports self-administration, improves patient compliance, and allows for consistent systemic exposure across a wide range of drug classes. Tablets, capsules, liquids, and powders are standard formats, with controlled-release and site-specific systems enhancing therapeutic outcomes.

This route is commonly used in managing chronic conditions such as diabetes, hypertension, cardiovascular disorders, neurological diseases, and infectious illnesses. For many APIs, oral delivery provides sufficient bioavailability, predictable absorption profiles, and easy formulation scalability. As a result, it continues to be the preferred choice for both over-the-counter medications and long-term prescription therapies.

What Technological Innovations Are Enhancing Oral Delivery Performance?

Technological advancements in drug formulation are overcoming traditional barriers such as poor solubility, low permeability, and first-pass metabolism. Techniques like solid dispersion, self-emulsifying systems, nanoencapsulation, and polymer-based carriers are improving bioavailability of poorly soluble drugs. Enteric coatings and mucoadhesive platforms are ensuring targeted delivery and protection against gastric degradation.

Modified-release systems, including extended-release tablets and osmotic pump formulations, are enabling sustained drug levels over longer durations. Multiparticulate and orally disintegrating tablets are enhancing dosing flexibility, especially in pediatric and geriatric populations. New excipient technologies and 3D printing are also facilitating personalized dose customization, supporting the rise of precision medicine in oral formulations.

Where Is Demand Expanding and Which Therapeutic Segments Lead Usage?

Demand for oral drug delivery is increasing in both developed and emerging markets, particularly in chronic disease management and home-based care. Cardiovascular, metabolic, and psychiatric drugs remain key drivers of oral formulation demand. Oncology is also adopting oral drugs for targeted therapy, especially where continuous dosing is required. Anti-infectives, gastrointestinal medications, and hormone therapies also rely heavily on oral formats.

Pediatric and geriatric populations are spurring demand for novel oral delivery options such as mini-tablets, flavored suspensions, and chewable formats. In oncology, oral targeted therapies and hormonal agents are supporting outpatient care, reducing the need for infusion visits. In low-resource settings, oral formats support large-scale public health distribution due to their ease of storage and administration.

Growth in the Oral Drug Delivery market is driven by several factors…

Growth in the oral drug delivery market is driven by factors such as the rising prevalence of chronic diseases, improvements in formulation science, and increased preference for non-invasive, self-administered therapies. Advancements in solubility enhancement and controlled-release technologies are enabling better therapeutic efficacy and patient adherence.

Adoption of oral targeted drugs in oncology and long-term infectious disease treatment is expanding, supported by investments in drug stability, bioavailability, and gastrointestinal targeting. Expanding pharmaceutical production in Asia-Pacific and increasing regulatory approvals for oral formulations across diverse indications are further supporting global market growth. Demand for patient-friendly, compliance-oriented drug delivery formats is reinforcing the sustained role of oral systems in modern pharmacotherapy.

SCOPE OF STUDY:

The report analyzes the Oral Drug Delivery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Tablets Form, Capsules Form, Drops Form, Liquid or Syrup Form); Type (Controlled Release, Orodispersible Tablets, Other Types); Therapy Area (Oncology Therapy Area, Musculoskeletal Therapy Area, Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Adare Pharma Solutions
  • Aquestive Therapeutics
  • Catalent Pharma Solutions
  • Croda International Plc
  • Entera Bio Ltd.
  • Enteris BioPharma Inc.
  • Graviti Pharmaceuticals
  • LTS Lohmann Therapie-Systeme AG
  • Lyndra Therapeutics
  • Murli Krishna Pharma Pvt. Ltd.
  • Nektar Therapeutics
  • Oramed Pharmaceuticals
  • Par Pharmaceutical
  • Pfizer Inc.
  • Polymedix Technologies (Adhex)
  • Rani Therapeutics
  • Rubicon Research
  • Sigmoid Pharma
  • SPI Pharma
  • Tapemark

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP37599

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Oral Drug Delivery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Patient-Friendly Drug Administration Spurs Adoption of Oral Delivery Platforms
    • Growth in Chronic Disease Management Strengthens Business Case for Sustained-Release Oral Formulations
    • Advancements in Nanotechnology and Lipid-Based Carriers Enhance Bioavailability of Oral Drugs
    • Expansion of Geriatric and Pediatric Patient Populations Drives Demand for Easy-to-Administer Oral Dosage Forms
    • Proliferation of Controlled and Targeted Release Technologies Propels Market for Modified Oral Delivery Systems
    • Integration of Polymer Science and 3D Printing Enables Customization of Oral Drug Formats
    • Regulatory Push for Generic Substitutes Supports Growth in Solid Oral Dosage Market
    • Increased R&D in Poorly Soluble Drug Candidates Generates Demand for Advanced Oral Delivery Techniques
    • Adoption of Buccal, Sublingual, and Orally Disintegrating Tablets Expands Options for Non-Traditional Oral Routes
    • Growing Use of Oral Delivery in Biologics and Peptide Therapeutics Throws the Spotlight on Protective Coating Innovations
    • Rising Healthcare Access in Developing Countries Accelerates Demand for Cost-Effective Oral Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Oral Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Oral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Oral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Oral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Capsules Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Capsules Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Capsules Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drops Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drops Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Drops Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Liquid or Syrup Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Liquid or Syrup Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Liquid or Syrup Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Immunology Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Immunology Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Immunology Therapy Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Gastrointestinal Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Gastrointestinal Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Gastrointestinal Therapy Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Respiratory Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Respiratory Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Respiratory Therapy Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cardiovascular Therapy Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Therapy Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Therapy Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Therapy Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Oncology Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Oncology Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Oncology Therapy Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Musculoskeletal Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Musculoskeletal Therapy Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Musculoskeletal Therapy Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Controlled Release by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Controlled Release by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Controlled Release by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Orodispersible Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Orodispersible Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: World 16-Year Perspective for Orodispersible Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 62: USA Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: USA 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Canada 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Canada 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • JAPAN
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Japan 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Japan 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Japan 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • CHINA
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 98: China Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: China 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: China 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: China 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: China 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • EUROPE
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Oral Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Oral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Europe 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Europe 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Europe 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • FRANCE
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 125: France Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: France 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: France 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 131: France Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: France 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: France 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • GERMANY
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Germany 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Germany 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Germany 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Germany 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Italy 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Italy 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Italy 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Italy 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 161: UK Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: UK 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 164: UK Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: UK 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 167: UK Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: UK 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: UK 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Spain 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Spain 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 179: Spain Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Spain Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Spain 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 182: Spain Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Spain Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Spain 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Russia 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Russia 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 191: Russia Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Russia Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Russia 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 194: Russia Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Russia Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Russia 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Europe 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Europe Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Europe 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Oral Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 16-Year Perspective for Oral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Asia-Pacific Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Asia-Pacific 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Australia 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Australia 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 230: Australia Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Australia Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Australia 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 233: Australia Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Australia Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Australia 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • INDIA
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 236: India Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: India 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 239: India Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: India 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 242: India Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: India Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: India 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 245: India Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: India Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: India 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: South Korea 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: South Korea 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 254: South Korea Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: South Korea Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: South Korea 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 257: South Korea Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: South Korea Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: South Korea 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Asia-Pacific Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Rest of Asia-Pacific Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Oral Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Latin America 16-Year Perspective for Oral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Latin America 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Latin America 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 281: Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Latin America Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Latin America 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 284: Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Latin America Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Latin America 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Argentina 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Argentina 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 293: Argentina Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Argentina Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Argentina 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 296: Argentina Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Argentina Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Argentina 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Brazil 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Brazil 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 305: Brazil Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Brazil Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Brazil 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 308: Brazil Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Brazil Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Brazil 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Mexico 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 316: Mexico 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 317: Mexico Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Mexico Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 319: Mexico 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 320: Mexico Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Mexico Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 322: Mexico 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Rest of Latin America Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 331: Rest of Latin America 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Rest of Latin America Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 334: Rest of Latin America 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Oral Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 337: Middle East 16-Year Perspective for Oral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 340: Middle East 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 343: Middle East 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 344: Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Middle East Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 346: Middle East 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 347: Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Middle East Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 349: Middle East 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 352: Iran 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 355: Iran 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 356: Iran Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Iran Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 358: Iran 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 359: Iran Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Iran Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 361: Iran 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 364: Israel 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 367: Israel 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 368: Israel Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Israel Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 370: Israel 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 371: Israel Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Israel Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 373: Israel 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Saudi Arabia Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 382: Saudi Arabia 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Saudi Arabia Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 385: Saudi Arabia 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 388: UAE 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 391: UAE 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 392: UAE Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: UAE Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 394: UAE 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 395: UAE Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: UAE Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 397: UAE 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Rest of Middle East Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 406: Rest of Middle East 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Rest of Middle East Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 409: Rest of Middle East 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030
  • AFRICA
    • Oral Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Oral Drug Delivery by Form - Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 412: Africa 16-Year Perspective for Oral Drug Delivery by Form - Percentage Breakdown of Value Sales for Tablets Form, Capsules Form, Drops Form and Liquid or Syrup Form for the Years 2014, 2025 & 2030
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Oral Drug Delivery by Therapy Area - Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 415: Africa 16-Year Perspective for Oral Drug Delivery by Therapy Area - Percentage Breakdown of Value Sales for Immunology Therapy Area, Gastrointestinal Therapy Area, Respiratory Therapy Area, Cardiovascular Therapy Area, Other Therapy Areas, Oncology Therapy Area and Musculoskeletal Therapy Area for the Years 2014, 2025 & 2030
    • TABLE 416: Africa Recent Past, Current & Future Analysis for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Africa Historic Review for Oral Drug Delivery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 418: Africa 16-Year Perspective for Oral Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use, Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 419: Africa Recent Past, Current & Future Analysis for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Africa Historic Review for Oral Drug Delivery by Type - Controlled Release, Orodispersible Tablets and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 421: Africa 16-Year Perspective for Oral Drug Delivery by Type - Percentage Breakdown of Value Sales for Controlled Release, Orodispersible Tablets and Other Types for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!